Weiguo Ye - 24 Mar 2025 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role
Chief Operating Officer
Signature
/s/ Ruoyu Chen, as attorney-in-fact for Weiguo Ye
Issuer symbol
GYRE
Transactions as of
24 Mar 2025
Net transactions value
+$487,500
Form type
4
Filing time
25 Apr 2025, 16:01:13 UTC
Previous filing
11 Mar 2025
Next filing
14 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GYRE Common Stock Options Exercise $225,000 +300,000 $0.7500 300,000 24 Mar 2025 Direct
transaction GYRE Common Stock Options Exercise $150,000 +200,000 +67% $0.7500 500,000 26 Mar 2025 Direct
transaction GYRE Common Stock Options Exercise $112,500 +150,000 +30% $0.7500 650,000 27 Mar 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GYRE Stock Option (Right to Buy) Options Exercise $0 -300,000 -18% $0.000000 1,365,115 24 Mar 2025 Common Stock 300,000 $0.7500 Direct F1
transaction GYRE Stock Option (Right to Buy) Options Exercise $0 -200,000 -15% $0.000000 1,165,115 26 Mar 2025 Common Stock 200,000 $0.7500 Direct F1
transaction GYRE Stock Option (Right to Buy) Options Exercise $0 -150,000 -13% $0.000000 1,015,115 27 Mar 2025 Common Stock 150,000 $0.7500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are vested in full.